Apeptico Forschung und Entwicklung GmbH
3 clinical trials · Sponsor
◉ Watch Apeptico Forschung und Entwicklung GmbH
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS (NCT03567577) | Apeptico Forschung und Entwicklung GmbH | 2018-05-23 |
| Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation (NCT02095626) | Apeptico Forschung und Entwicklung GmbH | 2013-06-01 |
| Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury (NCT01627613) | Apeptico Forschung und Entwicklung GmbH | 2012-07-01 |
Track Apeptico Forschung und Entwicklung GmbH automatically
Every clearance here is in the API, with alerts when new ones post.